Product
vedolizumab
Aliases
Entyvio, ENTYVIO
Name
ENTYVIO
1 clinical trial
1 drug
1 indication
Indication
MelanomaDrug
vedolizumabClinical trial
An Open-Label, Phase 1b, Multi-Arm Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of Investigational Treatments in Combination With Standard of Care Immune Checkpoint Inhibitors in Patients With Advanced MelanomaStatus: Terminated, Estimated PCD: 2018-05-11